Lifescan Labs of Illinois, LLC

Lifescan Labs of Illinois, LLC was paid $57.98M by Medicaid between May 2019 and May 2024, across 117 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 66% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Illinois

Rank by total paid#2 of 235

Median peer was paid$123K

This provider vs. median472×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2019	150,301	$766K
2020	313,355	$8.13M
2021	593,182	$18.17M
2022	826,708	$25.73M
2023	246,665	$4.75M
2024incomplete	76,940	$436K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	66%	593,607	158,008	$38.42M
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	12%	342,332	105,541	$6.81M
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	10.0%	285,477	81,585	$5.78M
80053	Comprehensive metabolic panel	1.5%	101,906	70,352	$884K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	1.4%	10,110	5,841	$803K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	1.3%	145,504	83,972	$727K
G2024	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source	<1%	21,873	6,630	$518K
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	<1%	205,570	101,714	$488K
84443	Thyroid stimulating hormone (TSH)	<1%	28,782	24,736	$404K
80048	Basic metabolic panel (calcium, ionized)	<1%	50,447	30,096	$345K
83036	Hemoglobin; glycosylated (A1C)	<1%	36,489	32,030	$205K
80061	Lipid panel	<1%	38,528	32,982	$198K

105 more codes

82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	19,470	$183K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	4,258	$169K
85027		<1%	29,812	$163K
80164		<1%	18,811	$143K
87086	Culture, bacterial; quantitative colony count, urine	<1%	14,217	$121K
85610		<1%	36,443	$120K
86141		<1%	6,703	$96K
82607		<1%	8,389	$89K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	1,963	$84K
87186		<1%	7,663	$82K
80185		<1%	5,956	$66K
80177		<1%	7,985	$65K
83735		<1%	10,466	$58K
84153		<1%	4,743	$54K
87493		<1%	1,449	$54K
80202		<1%	4,430	$51K
83880		<1%	3,079	$49K
82746		<1%	4,325	$43K
87040		<1%	2,574	$42K
81001		<1%	15,445	$37K
80076		<1%	4,762	$31K
G0471	Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha)	<1%	22,994	$28K
P9603	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled	<1%	16,513	$26K
85651		<1%	6,038	$24K
82140		<1%	3,539	$24K
80050	General health panel	<1%	1,408	$24K
84439		<1%	3,034	$23K
82728		<1%	3,447	$23K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	438	$21K
80178		<1%	3,253	$18K
83540		<1%	3,061	$17K
84480		<1%	1,980	$17K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	127	$17K
82947		<1%	4,933	$16K
84145		<1%	1,131	$15K
86769		<1%	394	$15K
87070		<1%	2,843	$15K
84132		<1%	3,610	$14K
87088		<1%	1,547	$14K
84100		<1%	4,414	$13K
84436		<1%	2,438	$13K
87184		<1%	1,557	$13K
82248		<1%	3,534	$12K
84134		<1%	2,174	$12K
80156		<1%	1,563	$12K
83550		<1%	1,402	$10K
87205		<1%	2,777	$8K
84703		<1%	1,196	$8K
80069		<1%	1,071	$8K
82274		<1%	848	$8K
82550		<1%	1,477	$7K
86803		<1%	448	$7K
87340		<1%	576	$7K
80162		<1%	613	$6K
86701		<1%	527	$6K
86592		<1%	1,680	$6K
86804		<1%	521	$6K
82951		<1%	737	$6K
84550		<1%	1,556	$5K
86140		<1%	1,143	$5K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	305	$5K
86702		<1%	525	$5K
82565		<1%	1,562	$4K
86706		<1%	356	$4K
84466		<1%	501	$4K
87147		<1%	1,338	$4K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	80	$3K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	78	$3K
87077		<1%	2,630	$3K
83690		<1%	273	$2K
36415	Collection of venous blood by venipuncture	<1%	6,423	$2K
80051		<1%	460	$2K
85049		<1%	787	$2K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	55	$1K
83615		<1%	304	$1K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	24	$1K
85730		<1%	264	$1K
84520		<1%	771	$1K
84450		<1%	572	$1K
80184		<1%	166	$1K
82310		<1%	541	$924.36
82040		<1%	481	$908.92
87481		<1%	20	$833.31
87390		<1%	35	$758.82
84481		<1%	88	$755.63
87081		<1%	130	$728.67
86709		<1%	128	$675.21
84460		<1%	363	$586.64
84484		<1%	70	$501.70
84075		<1%	353	$475.63
82247		<1%	349	$459.73
84155		<1%	354	$343.99
87102		<1%	62	$286.36
84295		<1%	155	$229.59
82374		<1%	140	$166.47
82435		<1%	141	$159.47
82150		<1%	29	$151.44
87075		<1%	14	$147.04
87045		<1%	16	$140.03
80159		<1%	15	$112.32
87899		<1%	13	$100.69
82043		<1%	14	$52.58
85018		<1%	19	$41.67
87220		<1%	12	$35.60
83721		<1%	25	$9.34

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKUTOFF, ELIYAHU (CEO)